18291017

Source:http://linkedlifedata.com/resource/pubmed/id/18291017

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005558, umls-concept:C0376358, umls-concept:C0444669, umls-concept:C1522609, umls-concept:C1524062, umls-concept:C1554112
pubmed:issue	6
pubmed:dateCreated	2008-2-22
pubmed:abstractText	To determine the value of a hypoechoic lesion (HL)-directed biopsy in addition to a systematic sextant biopsy for detecting prostate cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100886721
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1464-410X
pubmed:author	pubmed-author:GosselaarClaartjeC, pubmed-author:RoemelingStijnS, pubmed-author:RoobolMonique JMJ, pubmed-author:SchröderFritz HFH, pubmed-author:WoltersTinekeT, pubmed-author:van LeendersGeert J L HGJ
pubmed:issnType	Electronic
pubmed:volume	101
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	685-90
pubmed:meshHeading	pubmed-meshheading:18291017-Aged, pubmed-meshheading:18291017-Biopsy, pubmed-meshheading:18291017-Cohort Studies, pubmed-meshheading:18291017-Humans, pubmed-meshheading:18291017-Male, pubmed-meshheading:18291017-Mass Screening, pubmed-meshheading:18291017-Middle Aged, pubmed-meshheading:18291017-Predictive Value of Tests, pubmed-meshheading:18291017-Prostate, pubmed-meshheading:18291017-Prostate-Specific Antigen, pubmed-meshheading:18291017-Prostatic Neoplasms, pubmed-meshheading:18291017-Sensitivity and Specificity
pubmed:year	2008
pubmed:articleTitle	The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer.
pubmed:affiliation	Department of Urology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands. c.gosselaar@erasmusmc.nl
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Validation Studies